Abstract
GH treatment for short children is representative of many frontline issues in health care policy. In this paper, we highlight key policy issues exemplified by GH, focusing on pharmaceutical innovation, insurance coverage and pricing, and physician decisions, and we discuss their implications for endocrinology and GH use. Copyright © 2010 by The Endocrine Society.
Cite
CITATION STYLE
APA
Cuttler, L., & Silvers, J. B. (2010). Growth hormone and health policy. Journal of Clinical Endocrinology and Metabolism. Endocrine Society. https://doi.org/10.1210/jc.2009-2688
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free